Search
Kodiak Sciences Inc
KODAdd to Watchlist
36.000USD
-1.050-2.83%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
2.25BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-2.83%
5 Days
+0.81%
1 Month
-0.63%
6 Months
+15.83%
Year to Date
+28.76%
1 Year
+897.23%
Key Figures
37.120Open
38.340High
636.41KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.03%Turnover Ratio
37.050Prev. Close
35.545Low
16.77MTurnover
LossP/E Static
14.13P/B
0.00%Div Yield TTM
-76.39%ROA
47.84252wk High
0.86Volume Ratio
-176.21MNet Profit
61.76MShares
-4.1728EPS TTM
2.23Beta
-208.80%ROE
3.26052wk Low
7.54%Amplitude
--Gross Margin
2.25BMarket Cap
0.44Reward/Risk
6.65%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Kodiak Sciences Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Kodiak Sciences Inc Info
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab tedromer, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy and wet age-related macular degeneration. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate designed to inhibit interleukin-6 (IL-6)-mediated inflammation and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Ticker SymbolKOD
CompanyKodiak Sciences Inc
CEOPerlroth (Victor)
Websitehttps://kodiak.com/
Related Instruments
+0.90%
+0.82%
+0.08%
-0.14%
+0.88%
+0.83%
+1.27%
-0.02%
+0.09%
-2.71%
+1.45%
-0.89%
-1.86%
-0.65%
+0.41%
0.00%
+0.87%
+1.80%
-0.11%
-0.76%Popular Instruments
51922.400
-49.300 (-0.10%)
29833.600
+39.400 (+0.13%)
7414.100
+3.700 (+0.05%)
15801.000
+264.000 (+1.70%)
72343.000
+1386.000 (+1.95%)
6258.400
+30.200 (+0.48%)
69.484
-0.275 (-0.39%)
293.080
-1.220 (-0.41%)
199.000
-1.040 (-0.52%)
3988.040
-10.700 (-0.27%)
FAQs
What is the current price of Kodiak Sciences Inc (KOD)?
The current price of Kodiak Sciences Inc (KOD) is 36.00.
What is the symbol of Kodiak Sciences Inc?
The ticker symbol of Kodiak Sciences Inc is KOD.
What is the 52-week high of Kodiak Sciences Inc?
The 52-week high of Kodiak Sciences Inc is 47.84.
What is the 52-week low of Kodiak Sciences Inc?
The 52-week low of Kodiak Sciences Inc is 3.26.
What is the market capitalization of Kodiak Sciences Inc?
The market capitalization of Kodiak Sciences Inc is 2.22B.
Is Kodiak Sciences Inc (KOD) currently rated as Buy, Hold, or Sell?
According to analysts, Kodiak Sciences Inc (KOD) has an overall rating of Buy, with a price target of 64.00.
What is the Earnings Per Share (EPS TTM) of Kodiak Sciences Inc (KOD)?
The Earnings Per Share (EPS TTM) of Kodiak Sciences Inc (KOD) is -4.32.
